|
|
US Stem Cell Banking Company Receives Investment from Asia
publication date: Sep 3, 2008
NeoStem, Inc. completed a $1.25 million private placement from RimAsia Capital Partners, a pan-Asia private equity firm. This appears to be RimAsia’s first investment in a Western company. Previously, RimAsia's invested only in China-based enterprises. According to a statement from Dr. Robin Smith, Chairman and CEO of NeoStem, RimAsia is a “regional network of strategic investors drawn from leading Asian families and companies.” More details...
Stock Symbols: (AMEX: NBS)
|
ChinaBio® Events
ChinaBio® Partnering Forum 2012May 23-24, 2012 Suzhou, China >>More events...
Partner Events
 China Healthcare Investment Conference 2012March 13-15, 2012 Shanghai, China Shanghai CEO ConferenceMarch 28-29, 2012 Shanghai, China >>More details...
Other Events
China Pharmaceutical R&D SummitApril 23-26, 2012 Shanghai, China Biosimilars Asia 2012April 23-26, 2012 Shanghai, China Vaccines China 2012April 23-26, 2012 Shanghai, China
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners
![]()
|